Thomas, P, Mathur, P, Gottesman, II, Nagpal, Nimgaonkar, R VL, Deshpande, SN. Correlates of hallucinations in schizophrenia: a cross-cultural evaluation. Schizophr Res. 2007 May;92(1–3):41–9.CrossRefGoogle ScholarPubMed

Andreasen, NC, Flaum, M. Schizophrenia: the characteristic symptoms. Schizophr Bull. 1991;17(1):27–49.10.1093/schbul/17.1.27CrossRefGoogle ScholarPubMed

Jaspers, K, Jaspers, K. General psychopathology: volume two. Baltimore: Johns Hopkins University Press; 1997. (A Johns Hopkins paperback.)Google Scholar

Gage, SH, Hickman, M, Zammit, S. Association between cannabis and psychosis: epidemiologic evidence. Biol Psychiatry. 2016 Apr 1;79(7):549–56.CrossRefGoogle ScholarPubMed

Gage, SH, Jones, HJ, Burgess, S, Bowden, J, Davey Smith, G, Zammit, S, et al. Assessing causality in associations between cannabis use and schizophrenia risk: a two-sample Mendelian randomization study. Psychol Med. 2017 Apr;47(5):971–80.10.1017/S0033291716003172CrossRefGoogle Scholar

Power, RA, Verweij, KJH, Zuhair, M, Montgomery, GW, Henders, AK, Heath, AC, et al. Genetic predisposition to schizophrenia associated with increased use of cannabis. Mol Psychiatry. 2014 Nov;19(11):1201–4.CrossRefGoogle ScholarPubMed

Nieman, DH, Dragt, S, van Duin, EDA, Denneman, N, Overbeek, JM, de Haan, L, et al. COMT Val(158)Met genotype and cannabis use in people with an At Risk Mental State for psychosis: exploring gene × environment interactions. Schizophr Res. 2016 Jul;174(1–3):24–8.10.1016/j.schres.2016.03.015CrossRefGoogle Scholar

Boland, RJ, Verduin, ML, Ruiz, P, Shah, A, Sadock, BJ, editors. Kaplan & Sadock’s synopsis of psychiatry, 12th edition. Philadelphia: Wolters Kluwer; 2022.Google Scholar

Van Winkel, R, Kuepper, R. Epidemiological, neurobiological, and genetic clues to the mechanisms linking cannabis use to risk for nonaffective psychosis. Annu Rev Clin Psychol. 2014 Mar 28;10(1):767–91.10.1146/annurev-clinpsy-032813-153631CrossRefGoogle Scholar

Jones, PB, Barnes, TRE, Davies, L, Dunn, G, Lloyd, H, Hayhurst, KP, et al. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry. 2006 Oct;63(10):1079–87.10.1001/archpsyc.63.10.1079CrossRefGoogle Scholar

Németh, G, Laszlovszky, I, Czobor, P, Szalai, E, Szatmári, B, Harsányi, J, et al. Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial. Lancet. 2017 Mar 18;389(10074):1103–13.CrossRefGoogle ScholarPubMed

Siskind, D, Siskind, V, Kisely, S. Clozapine response rates among people with treatment-resistant schizophrenia: data from a systematic review and meta-analysis. Can J Psychiatry. 2017 Nov;62(11):772–7.10.1177/0706743717718167CrossRefGoogle ScholarPubMed

Sanahan, R, Sreeraj, VS, Suhas, S, Kumar, V, Thirthalli, J, Venkatasubramanian, G. Response to clozapine and its predictors in treatment-resistant schizophrenia spectrum disorders: a retrospective chart review. Schizophr Res. 2025 Jan;275:179–88.10.1016/j.schres.2024.12.015CrossRefGoogle ScholarPubMed

National Institute for Health and Care Excellence (NICE). Psychosis and schizophrenia in adults: prevention and management. Clinical guideline [CG178]. NICE; 2014. Available from: www.nice.org.uk/guidance/cg178Google Scholar

Fitzgerald, I, O’Connell, J, Keating, D, Hynes, C, McWilliams, S, Crowley, EK. Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology. Evid Based Ment Health. 2022 Feb;25(1):15–22.CrossRefGoogle ScholarPubMed

Howes, OD, McCutcheon, R, Agid, O, de Bartolomeis, A, van Beveren, NJM, Birnbaum, ML, et al. Treatment-resistant schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology. Am J Psychiatry. 2017 Mar 1;174(3):216–29.10.1176/appi.ajp.2016.16050503CrossRefGoogle Scholar

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

Meltzer, HY, Alphs, L, Green, AI, Altamura, AC, Anand, R, Bertoldi, A, et al. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry. 2003 Jan;60(1):82–91.CrossRefGoogle ScholarPubMed

Novick, D, Haro, JM, Bertsch, J, Haddad, PM. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study. J Clin Psychopharmacol. 2010 Oct;30(5):531–40.10.1097/JCP.0b013e3181f14098CrossRefGoogle ScholarPubMed

Ortí-Pareja, M, Jiménez-Jiménez, FJ, Vázquez, A, Catalán, MJ, Zurdo, M, Burguera, JA, et al. Drug-induced tardive syndromes. Parkinsonism Relat Disord. 1999 Apr;5(1–2):59–65.10.1016/S1353-8020(99)00015-2CrossRefGoogle ScholarPubMed

World Health Organization (WHO). Schizophrenia. 2022. Available from: www.who.int/news-room/fact-sheets/detail/schizophreniaGoogle Scholar

Puri, BK, Hall, AD, Ho, R. Revision notes in psychiatry, 3rd edition. Boca Raton: CRC Press/Taylor & Francis Group; 2014.Google Scholar

Taylor, DM, Barnes, TRE, Young, A. The Maudsley prescribing guidelines in psychiatry, 14th edition. Chichester Hoboken, NJ: Wiley Blackwell; 2021.10.1002/9781119870203CrossRefGoogle Scholar

Yung, AR, McGorry, PD, McFarlane, CA, Jackson, HJ, Patton, GC, Rakkar, A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull. 1996;22(2):283–303.CrossRefGoogle ScholarPubMed

Yung, AR, Yuen, HP, McGorry, PD, Phillips, LJ, Kelly, D, Dell’Olio, M, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry. 2005;39(11–12):964–71.CrossRefGoogle ScholarPubMed

Orygen, The National Centre of Excellence, in Youth Mental Health. Australian Clinical Guidelines for Early Psychosis, 2nd edition. Parkville: Orygen; 2016.Google Scholar

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Taylor, DM, Barnes, TRE, Young, A. The Maudsley prescribing guidelines in psychiatry, 14th edition. Chichester Hoboken, NJ: Wiley Blackwell; 2021.10.1002/9781119870203CrossRefGoogle Scholar

Terp, IM, Mortensen, PB. Post-partum psychoses. Clinical diagnoses and relative risk of admission after parturition. Br J Psychiatry. 1998 Jun;172:521–6.10.1192/bjp.172.6.521CrossRefGoogle ScholarPubMed

Videbech, P, Gouliaev, G. First admission with puerperal psychosis: 7–14 years of follow-up. Acta Psychiatr Scand. 1995 Mar;91(3):167–73.10.1111/j.1600-0447.1995.tb09761.xCrossRefGoogle Scholar

Kendell, RE, Chalmers, JC, Platz, C. Epidemiology of puerperal psychoses. Br J Psychiatry. 1987 May;150:662–73.10.1192/bjp.150.5.662CrossRefGoogle ScholarPubMed

Kendler, KS. Demography of paranoid psychosis (delusional disorder): a review and comparison with schizophrenia and affective illness. Arch Gen Psychiatry. 1982 Aug;39(8):890–902.10.1001/archpsyc.1982.04290080012003CrossRefGoogle ScholarPubMed

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Rush, JA, First, MB, Blacker, D. Handbook of psychiatric measures, 2nd edition. Washington: American Psychiatric Publishing; 2008.Google Scholar

Kroenke, K, Spitzer, RL, Williams, JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606–13.10.1046/j.1525-1497.2001.016009606.xCrossRefGoogle ScholarPubMed

Monroe, SM, Slavich, GM, Gotlib, IH. Life stress and family history for depression: the moderating role of past depressive episodes. J Psychiatr Res. 2014 Feb;49:90–5.10.1016/j.jpsychires.2013.11.005CrossRefGoogle ScholarPubMed

Patten, SB. Are the Brown and Harris “vulnerability factors” risk factors for depression? J Psychiatry Neurosci. 1991 Dec;16(5):267–71.Google Scholar

Friborg, O, Martinsen, EW, Martinussen, M, Kaiser, S, Overgård, KT, Rosenvinge, JH. Comorbidity of personality disorders in mood disorders: a meta-analytic review of 122 studies from 1988 to 2010. J Affect Disord. 2014 Jan;152–154:1–11.CrossRefGoogle ScholarPubMed

Davis, L, Uezato, A, Newell, JM, Frazier, E. Major depression and comorbid substance use disorders. Curr Opin Psychiatry. 2008 Jan;21(1):14–8.10.1097/YCO.0b013e3282f32408CrossRefGoogle ScholarPubMed

Calkins, AW, Rogers, AH, Campbell, AA, Simon, NM. Comorbidity of anxiety and depression. In Ressler, KJ, Pine, DS, Rothbaum, BO, editors. Anxiety disorders. Oxford: Oxford University Press; 2015, 299–314. Available from: https://academic.oup.com/book/24459/chapter/18752235210.1093/med/9780199395125.003.0021CrossRefGoogle Scholar

Hasin, DS, Goodwin, RD, Stinson, FS, Grant, BF. Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch Gen Psychiatry. 2005 Oct;62(10):1097–106.10.1001/archpsyc.62.10.1097CrossRefGoogle ScholarPubMed

Kennedy, SH, Lam, RW, McIntyre, RS, Tourjman, SV, Bhat, V, Blier, P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments. Can J Psychiatry. 2016 Sep;61(9):540–60.Google Scholar

National Institute for Health and Care Excellence (NICE). Depression in children and young people: identification and management. NICE guideline [NG134]. NICE; 2019. Available from: www.nice.org.uk/guidance/ng134Google Scholar

Medicines and Healthcare products Regulatory Agency (MHRA) Committee on the Safety of Medicine. Report of the CSM expert working group on the safety of selective serotonin reuptake inhibitor antidepressants. MHRA; 2014. Available from: www.gov.uk/government/publications/ssris-and-snris-use-and-safetyGoogle Scholar

US Food and Drug Administration (FDA). Suicidality in children and adolescents being treated with antidepressant medications. FDA; 2018. Available from: www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/suicidality-children-and-adolescents-being-treated-antidepressant-medicationsGoogle Scholar

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

Rush, AJ, Trivedi, MH, Wisniewski, SR, Nierenberg, AA, Stewart, JW, Warden, D, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry. 2006 Nov;163(11):1905–17.10.1176/ajp.2006.163.11.1905CrossRefGoogle ScholarPubMed

NICE. Depression in adults: treatment and management. NICE guideline [NG222]. NICE; 2022. Available from: www.nice.org.uk/guidance/ng222Google Scholar

Ferrari, AJ, Charlson, FJ, Norman, RE, Patten, SB, Freedman, G, Murray, CJL, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010. PLoS Med. 2013 Nov;10(11):e1001547.10.1371/journal.pmed.1001547CrossRefGoogle ScholarPubMed

Boland, RJ, Verduin, ML, Ruiz, P, Shah, A, Sadock, BJ, editors. Kaplan & Sadock’s synopsis of psychiatry, 12th edition. Philadelphia: Wolters Kluwer; 2022.Google Scholar

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Boland, RJ, Verduin, ML, Ruiz, P, Shah, A, Sadock, BJ, editors. Kaplan & Sadock’s synopsis of psychiatry, 12th edition. Philadelphia: Wolters Kluwer; 2022.Google Scholar

Deuster, PA, Adera, T, South-Paul, J. Biological, social, and behavioral factors associated with premenstrual syndrome. Arch Fam Med. 1999;8(2):122–8.10.1001/archfami.8.2.122CrossRefGoogle ScholarPubMed

Borenstein, J, Chiou, CF, Dean, B, Wong, J, Wade, S. Estimating direct and indirect costs of premenstrual syndrome. J Occup Environ Med. 2005 Jan;47(1):26–33.10.1097/01.jom.0000150209.44312.d1CrossRefGoogle ScholarPubMed

Johnson, WG, Carr-Nangle, RE, Bergeron, KC. Macronutrient intake, eating habits, and exercise as moderators of menstrual distress in healthy women. Psychosom Med. 1995;57(4):324–30.10.1097/00006842-199507000-00003CrossRefGoogle ScholarPubMed

Wyatt, KM, Dimmock, PW, Jones, PW, Shaughn O’Brien, PM. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ. 1999 May 22;318(7195):1375–81.10.1136/bmj.318.7195.1375CrossRefGoogle ScholarPubMed

van Die, MD, Burger, HG, Teede, HJ, Bone, KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta Med. 2013 May;79(7):562–75.Google ScholarPubMed

Busse, JW, Montori, VM, Krasnik, C, Patelis-Siotis, I, Guyatt, GH. Psychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trials. Psychother Psychosom. 2009;78(1):6–15.10.1159/000162296CrossRefGoogle ScholarPubMed

Bhatia, SC, Bhatia, SK. Diagnosis and treatment of premenstrual dysphoric disorder. Am Fam Physician. 2002 Oct 1;66(7):1239–48.Google ScholarPubMed

Kersting, A, Brähler, E, Glaesmer, H, Wagner, B. Prevalence of complicated grief in a representative population-based sample. J Affect Disord. 2011 Jun;131(1–3):339–43.10.1016/j.jad.2010.11.032CrossRefGoogle Scholar

Friedman, MJ. Seeking the best bereavement-related diagnostic criteria. Am J Psychiatry. 2016 Sep 1;173(9):864–5.10.1176/appi.ajp.2016.16050580CrossRefGoogle ScholarPubMed

Boelen, PA, Smid, GE. Disturbed grief: prolonged grief disorder and persistent complex bereavement disorder. BMJ. 2017 May 18;357:j2016.10.1136/bmj.j2016CrossRefGoogle ScholarPubMed

Szanto, K, Prigerson, H, Houck, P, Ehrenpreis, L, Reynolds, CF. Suicidal ideation in elderly bereaved: the role of complicated grief. Suicide Life Threat Behav. 1997;27(2):194–207.10.1111/j.1943-278X.1997.tb00291.xCrossRefGoogle ScholarPubMed

Latham, AE, Prigerson, HG. Suicidality and bereavement: complicated grief as psychiatric disorder presenting greatest risk for suicidality. Suicide Life Threat Behav. 2004;34(4):350–62.10.1521/suli.34.4.350.53737CrossRefGoogle ScholarPubMed

Szanto, K, Shear, MK, Houck, PR, Reynolds, CF, Frank, E, Caroff, K, et al. Indirect self-destructive behavior and overt suicidality in patients with complicated grief. J Clin Psychiatry. 2006 Feb;67(2):233–9.10.4088/JCP.v67n0209CrossRefGoogle ScholarPubMed

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsm.Google Scholar

Taylor, DM, Barnes, TRE, Young, A. The Maudsley prescribing guidelines in psychiatry, 14th edition. Chichester Hoboken, NJ: Wiley Blackwell; 2021.CrossRefGoogle Scholar

National Institute for Health and Care Excellence (NICE). Bipolar disorder: assessment and management. Clinical guideline [CG185]. NICE; 2014. Available from: www.nice.org.uk/guidance/cg185Google Scholar

Baldessarini, RJ, Tondo, L, Davis, P, Pompili, M, Goodwin, FK, Hennen, J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 2006 Oct;8(5 Pt 2):625–39.10.1111/j.1399-5618.2006.00344.xCrossRefGoogle ScholarPubMed

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

Boland, RJ, Verduin, ML, Ruiz, P, Shah, A, Sadock, BJ, editors. Kaplan & Sadock’s synopsis of psychiatry, 12th edition. Philadelphia: Wolters Kluwer; 2022.Google Scholar

Finley, PR, Warner, MD, Peabody, CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet. 1995 Sep;29(3):172–91.10.2165/00003088-199529030-00004CrossRefGoogle ScholarPubMed

Kennedy, SH, Lam, RW, McIntyre, RS, Tourjman, SV, Bhat, V, Blier, P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological treatments. Can J Psychiatry. 2016 Sep;61(9):540–60.10.1177/0706743716659417CrossRefGoogle Scholar

Yatham, LN, Kennedy, SH, Parikh, SV, Schaffer, A, Bond, DJ, Frey, BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018 Mar;20(2):97–170.10.1111/bdi.12609CrossRefGoogle Scholar

Goodwin, FK, Jamison, KR. Manic-depressive illness: bipolar disorders and recurrent depression, 2nd edition. New York: Oxford University Press; 2007.Google Scholar

Lichtenstein, P, Yip, BH, Björk, C, Pawitan, Y, Cannon, TD, Sullivan, PF, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009 Jan 17;373(9659):234–9.CrossRefGoogle ScholarPubMed

Post, RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev. 2007;31(6):858–73.10.1016/j.neubiorev.2007.04.003CrossRefGoogle ScholarPubMed

Kupka, RW, Luckenbaugh, DA, Post, RM, Leverich, GS, Nolen, WA. Rapid and non-rapid cycling bipolar disorder: a meta-analysis of clinical studies. J Clin Psychiatry. 2003 Dec;64(12):1483–94.10.4088/JCP.v64n1213CrossRefGoogle ScholarPubMed

Lee, S, Tsang, A, Kessler, RC, Jin, R, Sampson, N, Andrade, L, et al. Rapid-cycling bipolar disorder: cross-national community study. Br J Psychiatry. 2010 Mar;196(3):217–25.10.1192/bjp.bp.109.067843CrossRefGoogle ScholarPubMed

Medicines and Healthcare products Regulatory Agency. Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell): new safety and educational materials to support regulatory measures in men and women under 55 years of age. Drug Safety Update. 2024 Jan;17(6):1). Available from: www.gov.uk/drug-safety-update/valproate-belvo-convulex-depakote-dyzantil-epilim-epilim-chrono-or-chronosphere-episenta-epival-and-syonellv-new-safety-and-educational-materials-to-support-regulatory-measures-in-men-and-women-under-55-years-of-ageGoogle Scholar

Richy, Florent. A post-authorization safety study (PASS) to evaluate the paternal exposure to valproate and the risk of neurodevelopmental disorders including autism spectrum disorders as well as congenital abnormalities in offspring – a population-based retrospective study. Study protocol EUPAS34201. European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCEPP); 2020. Available from: https://catalogues.ema.europa.eu/node/3611/administrative-detailsGoogle Scholar

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Wittchen, HU, Jacobi, F, Rehm, J, Gustavsson, A, Svensson, M, Jönsson, B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011 Sep;21(9):655–79.10.1016/j.euroneuro.2011.07.018CrossRefGoogle ScholarPubMed

Simon, NM. Generalized anxiety disorder and psychiatric comorbidities such as depression, bipolar disorder, and substance abuse. J Clin Psychiatry. 2009 Apr;70(Suppl 2):10–4.10.4088/JCP.s.7002.02CrossRefGoogle ScholarPubMed

Sharma, P, Rosário, MC, Ferrão, YA, Albertella, L, Miguel, EC, Fontenelle, LF. The impact of generalized anxiety disorder in obsessive–compulsive disorder patients. Psychiatry Res. 2021 Jun;300:113898.10.1016/j.psychres.2021.113898CrossRefGoogle ScholarPubMed

Brawman-Mintzer, O, Lydiard, RB, Emmanuel, N, Payeur, R, Johnson, M, Roberts, J, et al. Psychiatric comorbidity in patients with generalized anxiety disorder. Am J Psychiatry. 1993 Aug;150(8):1216–8.Google ScholarPubMed

Boland, RJ, Verduin, ML, Ruiz, P, Shah, A, Sadock, BJ, editors. Kaplan & Sadock’s synopsis of psychiatry, 12th edition. Philadelphia: Wolters Kluwer; 2022.Google Scholar

Bolton, JM, Cox, BJ, Afifi, TO, Enns, MW, Bienvenu, OJ, Sareen, J. Anxiety disorders and risk for suicide attempts: findings from the Baltimore Epidemiologic Catchment area follow-up study. Depress Anxiety. 2008 Jun 1;25(6):477–81.10.1002/da.20314CrossRefGoogle ScholarPubMed

National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management. Clinical guideline [CG113]. NICE; 2011. Available from: www.nice.org.uk/guidance/cg113Google Scholar

Kennedy, SH, Lam, RW, McIntyre, RS, Tourjman, SV, Bhat, V, Blier, P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological Treatments. Can J Psychiatry. 2016 Sep;61(9):540–60.10.1177/0706743716659417CrossRefGoogle Scholar

Bandelow, B, Seidler-Brandler, U, Becker, A, Wedekind, D, Rüther, E. Meta-analysis of randomized controlled comparisons of psychopharmacological and psychological treatments for anxiety disorders. World J Biol Psychiatry. 2007;8(3):175–87.10.1080/15622970601110273CrossRefGoogle ScholarPubMed

Roshanaei-Moghaddam, B, Pauly, MC, Atkins, DC, Baldwin, SA, Stein, MB, Roy-Byrne, P. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety? Depress Anxiety. 2011 Jul;28(7):560–7.10.1002/da.20829CrossRefGoogle ScholarPubMed

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Saisch, SG, Wessely, S, Gardner, WN. Patients with acute hyperventilation presenting to an inner-city emergency department. Chest. 1996 Oct;110(4):952–7.10.1378/chest.110.4.952CrossRefGoogle Scholar

National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management. Clinical guideline [CG113]. NICE; 2011. Available from: www.nice.org.uk/guidance/cg113Google Scholar

Kennedy, SH, Lam, RW, McIntyre, RS, Tourjman, SV, Bhat, V, Blier, P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological Treatments. Can J Psychiatry. 2016 Sep;61(9):540–60.10.1177/0706743716659417CrossRefGoogle Scholar

Furukawa, TA, Watanabe, N, Churchill, R. Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia. Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD004364.Google ScholarPubMed

Hofmann, SG, Smits, JAJ. Cognitive–behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008 Apr;69(4):621–32.Google ScholarPubMed

Shear, MK, Brown, TA, Barlow, DH, Money, R, Sholomskas, DE, Woods, SW, et al. Multicenter collaborative panic disorder severity scale. Am J Psychiatry. 1997 Nov;154(11):1571–5.10.1176/ajp.154.11.1571CrossRefGoogle ScholarPubMed

Bandelow, B. Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. Int Clin Psychopharmacol. 1995 Jun;10(2):73–81.10.1097/00004850-199506000-00003CrossRefGoogle ScholarPubMed

Taylor, DM, Barnes, TRE, Young, A. The Maudsley prescribing guidelines in psychiatry, 14th edition. Chichester Hoboken, NJ: Wiley Blackwell; 2021. 10.1002/9781119870203CrossRefGoogle Scholar

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Kessler, RC, Chiu, WT, Demler, O, Merikangas, KR, Walters, EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):617–27.Google ScholarPubMed

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

Goddard, AW, Mahmud, W, Medlock, C, Shin, YW, Shekhar, A. A controlled trial of quetiapine XR coadministration treatment of SSRI-resistant panic disorder. Ann Gen Psychiatry. 2015;14:26.10.1186/s12991-015-0064-0CrossRefGoogle ScholarPubMed

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Eaton, WW, Bienvenu, OJ, Miloyan, B. Specific phobias. Lancet Psychiatry. 2018 Aug;5(8):678–86.10.1016/S2215-0366(18)30169-XCrossRefGoogle ScholarPubMed

Baljé, A, Greeven, A, Van Giezen, A, Korrelboom, K, Arntz, A, Spinhoven, P. Group schema therapy versus group cognitive behavioral therapy for social anxiety disorder with comorbid avoidant personality disorder: study protocol for a randomized controlled trial. Trials. 2016 Dec;17(1):487.10.1186/s13063-016-1605-9CrossRefGoogle ScholarPubMed

Kennedy, SH, Lam, RW, McIntyre, RS, Tourjman, SV, Bhat, V, Blier, P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological Treatments. Can J Psychiatry. 2016 Sep;61(9):540–60.10.1177/0706743716659417CrossRefGoogle Scholar

Koyuncu, A, İnce, E, Ertekin, E, Tükel, R. Comorbidity in social anxiety disorder: diagnostic and therapeutic challenges. Drugs Context. 2019;8:212573.10.7573/dic.212573CrossRefGoogle ScholarPubMed

Taylor, DM, Barnes, TRE, Young, A. The Maudsley prescribing guidelines in psychiatry, 14th edition. Chichester Hoboken, NJ: Wiley Blackwell; 2021.10.1002/9781119870203CrossRefGoogle Scholar

Ipser, JC, Kariuki, CM, Stein, DJ. Pharmacotherapy for social anxiety disorder: a systematic review. Expert Rev Neurother. 2008 Feb;8(2):235–57.10.1586/14737175.8.2.235CrossRefGoogle ScholarPubMed

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Thapar, A. Rutter’s child and adolescent psychiatry, 6th edition. Chichester: Wiley; 2015.10.1002/9781118381953CrossRefGoogle Scholar

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Boland, RJ, Verduin, ML, Ruiz, P, Shah, A, Sadock, BJ, editors. Kaplan & Sadock’s synopsis of psychiatry, 12th edition. Philadelphia: Wolters Kluwer; 2022.Google Scholar

Goodman, WK, Price, LH, Rasmussen, SA, Mazure, C, Fleischmann, RL, Hill, CL, et al. The Yale–Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry. 1989 Nov;46(11):1006–11.Google ScholarPubMed

Pallanti, S, Grassi, G, Sarrecchia, ED, Cantisani, A, Pellegrini, M. Obsessive–compulsive disorder comorbidity: clinical assessment and therapeutic implications. Front Psychiatry. 2011;2:70.10.3389/fpsyt.2011.00070CrossRefGoogle ScholarPubMed

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Kaye, WH, Bulik, CM, Thornton, L, Barbarich, N, Masters, K. Comorbidity of anxiety disorders with anorexia and bulimia nervosa. Am J Psychiatry. 2004 Dec;161(12):2215–21.10.1176/appi.ajp.161.12.2215CrossRefGoogle ScholarPubMed

Angelakis, I, Gooding, P, Tarrier, N, Panagioti, M. Suicidality in obsessive compulsive disorder (OCD): a systematic review and meta-analysis. Clin Psychol Rev. 2015 Jul;39:1–15.10.1016/j.cpr.2015.03.002CrossRefGoogle ScholarPubMed

Kohn, R, Saxena, S, Levav, I, Saraceno, B. The treatment gap in mental health care. Bull World Health Organ. 2004 Nov;82(11):858–66.Google ScholarPubMed

Kennedy, SH, Lam, RW, McIntyre, RS, Tourjman, SV, Bhat, V, Blier, P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological Treatments. Can J Psychiatry. 2016 Sep;61(9):540–60.10.1177/0706743716659417CrossRefGoogle Scholar

Taylor, DM, Barnes, TRE, Young, A. The Maudsley prescribing guidelines in psychiatry, 14th edition. Chichester Hoboken, NJ: Wiley Blackwell; 2021.10.1002/9781119870203CrossRefGoogle Scholar

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

Ipser, JC, Carey, P, Dhansay, Y, Fakier, N, Seedat, S, Stein, DJ. Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders. Cochrane Database Syst Rev. 2006 Oct 18; 2006(4): CD005473. Available from: https://doi.wiley.com/10.1002/14651858.CD005473.pub2Google Scholar

Katzman, MA, Bleau, P, Blier, P, Chokka, P, Kjernisted, K, Van Ameringen, M, et al. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive–compulsive disorders. BMC Psychiatry. 2014;14(Suppl 1):S1.10.1186/1471-244X-14-S1-S1CrossRefGoogle ScholarPubMed

Greenberg, BD, Gabriels, LA, Malone, DA, Rezai, AR, Friehs, GM, Okun, MS, et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive–compulsive disorder: worldwide experience. Mol Psychiatry. 2010 Jan;15(1):64–79.10.1038/mp.2008.55CrossRefGoogle ScholarPubMed

Goodman, WK, Foote, KD, Greenberg, BD, Ricciuti, N, Bauer, R, Ward, H, et al. Deep brain stimulation for intractable obsessive compulsive disorder: pilot study using a blinded, staggered-onset design. Biol Psychiatry. 2010 Mar 15;67(6):535–42.10.1016/j.biopsych.2009.11.028CrossRefGoogle ScholarPubMed

Soomro, GM, Altman, D, Rajagopal, S, Oakley-Browne, M. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008 Jan 23;2008(1):CD001765.Google Scholar

Sasson, Y, Zohar, J, Chopra, M, Lustig, M, Iancu, I, Hendler, T. Epidemiology of obsessive–compulsive disorder: a world view. J Clin Psychiatry. 1997;58(Suppl 12):7–10.Google ScholarPubMed

Asbahr, FR, Negrão, AB, Gentil, V, Zanetta, DM, da Paz, JA, Marques-Dias, MJ, et al. Obsessive–compulsive and related symptoms in children and adolescents with rheumatic fever with and without chorea: a prospective 6-month study. Am J Psychiatry. 1998 Aug;155(8):1122–4.10.1176/ajp.155.8.1122CrossRefGoogle ScholarPubMed

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Phillips, KA, Hollander, E, Rasmussen, SA, Aronowitz, BR, DeCaria, C, Goodman, WK. A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale–Brown Obsessive Compulsive Scale. Psychopharmacol Bull. 1997;33(1):17–22.Google ScholarPubMed

Phillips, KA, Atala, KD, Pope, HG. Diagnostic instruments for body dysmorphic disorder. New Research Program and Abstracts, American Psychiatric Association 148th Annual Meeting, Miami; 1995, p. 157.Google Scholar

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Phillips, KA, Menard, W, Fay, C, Weisberg, R. Demographic characteristics, phenomenology, comorbidity, and family history in 200 individuals with body dysmorphic disorder. Psychosomatics. 2005;46(4):317–25.10.1176/appi.psy.46.4.317CrossRefGoogle ScholarPubMed

Gunstad, J, Phillips, KA. Axis I comorbidity in body dysmorphic disorder. Compr Psychiatry. 2003;44(4):270–6.10.1016/S0010-440X(03)00088-9CrossRefGoogle ScholarPubMed

Grant, JE, Menard, W, Pagano, ME, Fay, C, Phillips, KA. Substance use disorders in individuals with body dysmorphic disorder. J Clin Psychiatry. 2005 Mar;66(3):309–16; quiz 404–5.10.4088/JCP.v66n0306CrossRefGoogle ScholarPubMed

Phillips, KA, McElroy, SL. Personality disorders and traits in patients with body dysmorphic disorder. Compr Psychiatry. 2000;41(4):229–36.10.1053/comp.2000.7429CrossRefGoogle ScholarPubMed

Zimmerman, M, Mattia, JI. Body dysmorphic disorder in psychiatric outpatients: recognition, prevalence, comorbidity, demographic, and clinical correlates. Compr Psychiatry. 1998;39(5):265–70.10.1016/S0010-440X(98)90034-7CrossRefGoogle ScholarPubMed

Varma, A, Rastogi, R. Recognizing body dysmorphic disorder (dysmorphophobia). J Cutan Aesthet Surg. 2015;8(3):165–8.10.4103/0974-2077.167279CrossRefGoogle ScholarPubMed

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

Bohne, A, Wilhelm, S, Keuthen, NJ, Florin, I, Baer, L, Jenike, MA. Prevalence of body dysmorphic disorder in a German college student sample. Psychiatry Res. 2002 Jan 31;109(1):101–4.10.1016/S0165-1781(01)00363-8CrossRefGoogle Scholar

Koran, LM, Abujaoude, E, Large, MD, Serpe, RT. The prevalence of body dysmorphic disorder in the United States adult population. CNS Spectr. 2008 Apr;13(4):316–22.10.1017/S1092852900016436CrossRefGoogle ScholarPubMed

Buhlmann, U, Glaesmer, H, Mewes, R, Fama, JM, Wilhelm, S, Brähler, E, et al. Updates on the prevalence of body dysmorphic disorder: a population-based survey. Psychiatry Res. 2010 Jun 30;178(1):171–5.10.1016/j.psychres.2009.05.002CrossRefGoogle ScholarPubMed

Phillips, KA. Psychosis in body dysmorphic disorder. J Psychiatr Res. 2004 Jan;38(1):63–72.10.1016/S0022-3956(03)00098-0CrossRefGoogle ScholarPubMed

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Grant, JE, Redden, SA, Medeiros, GC, Odlaug, BL, Curley, EE, Tavares, H, et al. Trichotillomania and its clinical relationship to depression and anxiety. Int J Psychiatry Clin Pract. 2017 Nov;21(4):302–6.10.1080/13651501.2017.1314509CrossRefGoogle ScholarPubMed

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Boland, RJ, Verduin, ML, Ruiz, P, Shah, A, Sadock, BJ, editors. Kaplan & Sadock’s synopsis of psychiatry, 12th edition. Philadelphia: Wolters Kluwer; 2022.Google Scholar

Grant, JE, Chamberlain, SR. Trichotillomania and skin-picking disorder: an update. Focus (Am Psychiatr Publ). 2021 Oct;19(4):405–12.Google ScholarPubMed

Grant, JE, Chamberlain, SR. Automatic and focused hair pulling in trichotillomania: valid and useful subtypes? Psychiatry Res. 2021 Dec;306:114269.10.1016/j.psychres.2021.114269CrossRefGoogle ScholarPubMed

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Iervolino, AC, Perroud, N, Fullana, MA, Guipponi, M, Cherkas, L, Collier, DA, et al. Prevalence and heritability of compulsive hoarding: a twin study. Am J Psychiatry. 2009 Oct;166(10):1156–61.10.1176/appi.ajp.2009.08121789CrossRefGoogle ScholarPubMed

Anderson, SW, Damasio, H, Damasio, AR. A neural basis for collecting behaviour in humans. Brain. 2005 Jan;128(Pt 1):201–12.Google ScholarPubMed

Ayers, CR, Najmi, S, Mayes, TL, Dozier, ME. Hoarding disorder in older adulthood. Am J Geriatr Psychiatry. 2015 Apr;23(4):416–22.10.1016/j.jagp.2014.05.009CrossRefGoogle ScholarPubMed

Pertusa, A, Frost, RO, Fullana, MA, Samuels, J, Steketee, G, Tolin, D, et al. Refining the diagnostic boundaries of compulsive hoarding: a critical review. Clin Psychol Rev. 2010 Jun;30(4):371–86.10.1016/j.cpr.2010.01.007CrossRefGoogle ScholarPubMed

Nordsletten, AE, Reichenberg, A, Hatch, SL, Fernández de la Cruz, L, Pertusa, A, Hotopf, M, et al. Epidemiology of hoarding disorder. Br J Psychiatry. 2013 Dec;203(6):445–52.10.1192/bjp.bp.113.130195CrossRefGoogle ScholarPubMed

Frost, RO, Steketee, G, Tolin, DF. Comorbidity in hoarding disorder. Depress Anxiety. 2011 Oct 3;28(10):876–84.10.1002/da.20861CrossRefGoogle ScholarPubMed

Fullana, MA, Vilagut, G, Rojas-Farreras, S, Mataix-Cols, D, de Graaf, R, Demyttenaere, K, et al. Obsessive–compulsive symptom dimensions in the general population: results from an epidemiological study in six European countries. J Affect Disord. 2010 Aug;124(3):291–9.10.1016/j.jad.2009.11.020CrossRefGoogle ScholarPubMed

Mataix-Cols, D, Billotti, D, Fernández de la Cruz, L, Nordsletten, AE. The London field trial for hoarding disorder. Psychol Med. 2013 Apr;43(4):837–47.10.1017/S0033291712001560CrossRefGoogle ScholarPubMed

Tolin, DF, Meunier, SA, Frost, RO, Steketee, G. Hoarding among patients seeking treatment for anxiety disorders. J Anxiety Disord. 2011 Jan;25(1):43–8.10.1016/j.janxdis.2010.08.001CrossRefGoogle ScholarPubMed

Piacentino, D, Pasquini, M, Cappelletti, S, Chetoni, C, Sani, G, Kotzalidis, GD. Pharmacotherapy for hoarding disorder: how did the picture change since its excision from OCD? Curr Neuropharmacol. 2019;17(8):808–15.10.2174/1570159X17666190124153048CrossRefGoogle ScholarPubMed

Boland, RJ, Verduin, ML, Ruiz, P, Shah, A, Sadock, BJ, editors. Kaplan & Sadock’s synopsis of psychiatry, 12th edition. Philadelphia: Wolters Kluwer; 2022.Google Scholar

Harrison, PJ, Cowen, P, Burns, T, Fazel, M. Shorter Oxford textbook of psychiatry, 7th edition. Oxford: Oxford University Press; 2018.Google Scholar

Black, DW, Monahan, P, Gable, J, Blum, N, Clancy, G, Baker, P. Hoarding and treatment response in 38 nondepressed subjects with obsessive–compulsive disorder. J Clin Psychiatry. 1998;59:420–5.10.4088/JCP.v59n0804CrossRefGoogle ScholarPubMed

Frost, RO, Steketee, G, Tolin, DF, Renaud, S. Development and validation of the Clutter Image Rating. J Psychopathol Behav Assess. 2008 Sep;30(3):193–203.10.1007/s10862-007-9068-7CrossRefGoogle Scholar

Tolin, DF, Fitch, KE, Frost, RO, Steketee, G. Hoarding Rating Scale–Self-Report. Available from: https://doi.apa.org/doi/10.1037/t35976-000Google Scholar

Tolin, DF, Frost, RO, Steketee, G. A brief interview for assessing compulsive hoarding: the Hoarding Rating Scale-Interview. Psychiatry Res. 2010 Jun 30;178(1):147–52.10.1016/j.psychres.2009.05.001CrossRefGoogle ScholarPubMed

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

Morgan, JF, Reid, F, Lacey, JH. The SCOFF questionnaire: a new screening tool for eating disorders. West J Med. 2000 Mar;172(3):164–5.10.1136/ewjm.172.3.164CrossRefGoogle ScholarPubMed

Garner, DM, Olmsted, MP, Bohr, Y, Garfinkel, PE. Eating Attitude Test-26. American Psychological Association; 2013. Available from: http://doi.apa.org/getdoi.cfm?doi=10.1037/t07770-000Google Scholar

American Psychiatric Association. Treatment of patients with eating disorders, 3rd edition. American Psychiatric Association; 2006.Google Scholar

Arcelus, J, Mitchell, AJ, Wales, J, Nielsen, S. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies. Arch Gen Psychiatry. 2011 Jul;68(7):724–31.10.1001/archgenpsychiatry.2011.74CrossRefGoogle ScholarPubMed

Ponzo, V, Pellegrini, M, Cioffi, I, Scaglione, L, Bo, S. The refeeding syndrome: a neglected but potentially serious condition for inpatients. A narrative review. Intern Emerg Med. 2021 Jan;16(1):49–60.10.1007/s11739-020-02525-7CrossRefGoogle ScholarPubMed

American Dietetic Association. Position of the American Dietetic Association: nutrition intervention in the treatment of anorexia nervosa, bulimia nervosa, and other eating disorders. J Am Diet Assoc. 2006 Dec;106(12):2073–82.Google Scholar

Golden, NH, Meyer, W. Nutritional rehabilitation of anorexia nervosa. Goals and dangers. Int J Adolesc Med Health. 2004;16(2):131–44.10.1515/IJAMH.2004.16.2.131CrossRefGoogle ScholarPubMed

Claudino, AM, Hay, P, Lima, MS, Bacaltchuk, J, Schmidt, U, Treasure, J. Antidepressants for anorexia nervosa. Cochrane Database Syst Rev. 2006 Jan 25;2005(1):CD004365.Google Scholar

National Institute for Health and Care Excellence (NICE). Eating disorders: recognition and treatment. NICE guideline [NG69]. NICE; 2017. Available from: www.nice.org.uk/guidance/ng69Google Scholar

Goldberg, SJ, Comerci, GD, Feldman, L. Cardiac output and regional myocardial contraction in anorexia nervosa. J Adolesc Health Care. 1988 Jan;9(1):15–21.10.1016/0197-0070(88)90013-7CrossRefGoogle ScholarPubMed

Mehler, PS, Lezotte, D, Eckel, R. Lipid levels in anorexia nervosa. Int J Eat Disord. 1998 Sep;24(2):217–21.10.1002/(SICI)1098-108X(199809)24:2<217::AID-EAT11>3.0.CO;2-W3.0.CO;2-W>CrossRefGoogle ScholarPubMed

Katz, MG, Vollenhoven, B. The reproductive endocrine consequences of anorexia nervosa. BJOG. 2000 Jun;107(6):707–13.10.1111/j.1471-0528.2000.tb13329.xCrossRefGoogle ScholarPubMed

Bulik, CM, Hoffman, ER, Von Holle, A, Torgersen, L, Stoltenberg, C, Reichborn-Kjennerud, T. Unplanned pregnancy in women with anorexia nervosa. Obstet Gynecol. 2010 Nov;116(5):1136–40.10.1097/AOG.0b013e3181f7efdcCrossRefGoogle ScholarPubMed

Chaer, R, Nakouzi, N, Itani, L, Tannir, H, Kreidieh, D, El Masri, D, et al. Fertility and reproduction after recovery from anorexia nervosa: a systematic review and meta-analysis of long-term follow-up studies. Diseases. 2020 Dec 16;8(4):46.10.3390/diseases8040046CrossRefGoogle ScholarPubMed

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Forney, KJ, Buchman-Schmitt, JM, Keel, PK, Frank, GKW. The medical complications associated with purging. Int J Eat Disord. 2016 Mar;49(3):249–59.10.1002/eat.22504CrossRefGoogle ScholarPubMed

Dessureault, S, Coppola, D, Weitzner, M, Powers, P, Karl, RC. Barrett’s esophagus and squamous cell carcinoma in a patient with psychogenic vomiting. Int J Gastrointest Cancer. 2002;32(1):57–61.10.1385/IJGC:32:1:57CrossRefGoogle Scholar

Udo, T, Grilo, CM. Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States. Int J Eat Disord. 2019 Jan;52(1):42–50.10.1002/eat.23004CrossRefGoogle Scholar

Nobles, CJ, Thomas, JJ, Valentine, SE, Gerber, MW, Vaewsorn, AS, Marques, L. Association of premenstrual syndrome and premenstrual dysphoric disorder with bulimia nervosa and binge-eating disorder in a nationally representative epidemiological sample. Int J Eat Disord. 2016 Jul;49(7):641–50.10.1002/eat.22539CrossRefGoogle Scholar

Harrison, PJ, Cowen, P, Burns, T, Fazel, M. Shorter Oxford textbook of psychiatry, 7th edition. Oxford: Oxford University Press; 2018.Google Scholar

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Matson, JL, Hattier, MA, Belva, B, Matson, ML. Pica in persons with developmental disabilities: approaches to treatment. Res Dev Disabil. 2013 Sep;34(9):2564–71.10.1016/j.ridd.2013.05.018CrossRefGoogle ScholarPubMed

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Roy, A, Fuentes-Afflick, E, Fernald, LCH, Young, SL. Pica is prevalent and strongly associated with iron deficiency among Hispanic pregnant women living in the United States. Appetite. 2018 Jan 1;120:163–70.10.1016/j.appet.2017.08.033CrossRefGoogle ScholarPubMed

Sadeghzadeh, M, Khoshnevisasl, P, Sadeghzadeh, S. The relation between pica and iron deficiency in children in Zanjan, Islamic Republic of Iran: a case–control study. East Mediterr Health J. 2017 Aug 20;23(6):404–7.10.26719/2017.23.6.404CrossRefGoogle ScholarPubMed

Fleisher, DR. Functional vomiting disorders in infancy: innocent vomiting, nervous vomiting, and infant rumination syndrome. J Pediatr. 1994 Dec;125(6 Pt 2):S84–94.10.1016/S0022-3476(05)82931-2CrossRefGoogle ScholarPubMed

Barba, E, Burri, E, Accarino, A, Malagelada, C, Rodriguez-Urrutia, A, Soldevilla, A, et al. Biofeedback-guided control of abdominothoracic muscular activity reduces regurgitation episodes in patients with rumination. Clin Gastroenterol Hepatol. 2015 Jan;13(1):100–106.e1.10.1016/j.cgh.2014.04.018CrossRefGoogle ScholarPubMed

Levine, DF, Wingate, DL, Pfeffer, JM, Butcher, P. Habitual rumination: a benign disorder. Br Med J (Clin Res Ed). 1983 Jul 23;287(6387):255–6.10.1136/bmj.287.6387.255CrossRefGoogle ScholarPubMed

Halland, M, Parthasarathy, G, Bharucha, AE, Katzka, DA. Diaphragmatic breathing for rumination syndrome: efficacy and mechanisms of action. Neurogastroenterol Motil. 2016 Mar;28(3):384–91.10.1111/nmo.12737CrossRefGoogle ScholarPubMed

Almansa, C, Rey, E, Sánchez, RG, Sánchez, AA, Díaz-Rubio, M. Prevalence of functional gastrointestinal disorders in patients with fibromyalgia and the role of psychologic distress. Clin Gastroenterol Hepatol. 2009 Apr;7(4):438–45.10.1016/j.cgh.2008.12.005CrossRefGoogle ScholarPubMed

Kusnik, A VS. Rumination disorder. StatPearls. Treasure Island, FL: StatPearls Publishing; 2023. Available from: www.ncbi.nlm.nih.gov/books/NBK576404Google Scholar

Nyanza, EC, Joseph, M, Premji, SS, Thomas, DS, Mannion, C. Geophagy practices and the content of chemical elements in the soil eaten by pregnant women in artisanal and small scale gold mining communities in Tanzania. BMC Pregnancy Childbirth. 2014 Apr 15;14:144.10.1186/1471-2393-14-144CrossRefGoogle ScholarPubMed

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Smid, GE, Mooren, TTM, van der Mast, RC, Gersons, BPR, Kleber, RJ. Delayed posttraumatic stress disorder: systematic review, meta-analysis, and meta-regression analysis of prospective studies. J Clin Psychiatry. 2009 Nov;70(11):1572–82.10.4088/JCP.08r04484CrossRefGoogle ScholarPubMed

Weathers, FW, Bovin, MJ, Lee, DJ, Sloan, DM, Schnurr, PP, Kaloupek, DG, et al. The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): development and initial psychometric evaluation in military veterans. Psychol Assess. 2018 Mar;30(3):383–95.10.1037/pas0000486CrossRefGoogle ScholarPubMed

Blevins, CA, Weathers, FW, Davis, MT, Witte, TK, Domino, JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): development and initial psychometric evaluation. J Trauma Stress. 2015 Dec;28(6):489–98.10.1002/jts.22059CrossRefGoogle ScholarPubMed

Olff, M. Sex and gender differences in post-traumatic stress disorder: an update. Eur J Psychotraumatol. 2017 Sep 29;8(Suppl 4):1351204.10.1080/20008198.2017.1351204CrossRefGoogle Scholar

Brady, KT. Posttraumatic stress disorder and comorbidity: recognizing the many faces of PTSD. J Clin Psychiatry. 1997;58(Suppl 9):12–5.Google ScholarPubMed

Rose, SC, Bisson, J, Churchill, R, Wessely, S. Psychological debriefing for preventing post traumatic stress disorder (PTSD). Cochrane Database Syst Rev. 2002 Apr;2002(2):CD000560.Google Scholar

Harvey, AG, Bryant, RA. The relationship between acute stress disorder and posttraumatic stress disorder: a prospective evaluation of motor vehicle accident survivors. J Consult Clin Psychol. 1998 Jun;66(3):507–12.10.1037/0022-006X.66.3.507CrossRefGoogle ScholarPubMed

Brewin, CR, Andrews, B, Rose, S, Kirk, M. Acute stress disorder and posttraumatic stress disorder in victims of violent crime. Am J Psychiatry. 1999 Mar;156(3):360–6.10.1176/ajp.156.3.360CrossRefGoogle ScholarPubMed

Bryant, RA. Acute stress disorder as a predictor of posttraumatic stress disorder: a systematic review. J Clin Psychiatry. 2011 Feb;72(2):233–9.10.4088/JCP.09r05072bluCrossRefGoogle ScholarPubMed

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

Roberts, AL, Kubzansky, LD, Chibnik, LB, Rimm, EB, Koenen, KC. Association of posttraumatic stress and depressive symptoms with mortality in women. JAMA Netw Open. 2020 Dec 1;3(12):e2027935.10.1001/jamanetworkopen.2020.27935CrossRefGoogle ScholarPubMed

Gifford, J. Is it child sexual abuse? A general paediatrician’s guide. Paediatr Child Health. 2023 Jan;33(1):1–5.10.1016/j.paed.2022.10.006CrossRefGoogle Scholar

Kessler, RC, Berglund, P, Demler, O, Jin, R, Merikangas, KR, Walters, EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 Jun;62(6):593–602.10.1001/archpsyc.62.6.593CrossRefGoogle ScholarPubMed

Goldstein, RB, Smith, SM, Chou, SP, Saha, TD, Jung, J, Zhang, H, et al. The epidemiology of DSM-5 posttraumatic stress disorder in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions-III. Soc Psychiatry Psychiatr Epidemiol. 2016 Aug;51(8):1137–48.10.1007/s00127-016-1208-5CrossRefGoogle ScholarPubMed

Van Ameringen, M, Mancini, C, Patterson, B, Boyle, MH. Post-traumatic stress disorder in Canada. CNS Neurosci Ther. 2008;14(3):171–81.10.1111/j.1755-5949.2008.00049.xCrossRefGoogle ScholarPubMed

Koenen, KC, Ratanatharathorn, A, Ng, L, McLaughlin, KA, Bromet, EJ, Stein, DJ, et al. Posttraumatic stress disorder in the World Mental Health Surveys. Psychol Med. 2017 Oct;47(13):2260–74.10.1017/S0033291717000708CrossRefGoogle ScholarPubMed

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Boland, RJ, Verduin, ML, Ruiz, P, Shah, A, Sadock, BJ, editors. Kaplan & Sadock’s synopsis of psychiatry, 12th edition. Philadelphia: Wolters Kluwer; 2022.Google Scholar

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Mehndiratta, MM, Kumar, M, Nayak, R, Garg, H, Pandey, S. Hoover’s sign: clinical relevance in neurology. J Postgrad Med. 2014;60(3):297–9.10.4103/0022-3859.138769CrossRefGoogle ScholarPubMed

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

Feinstein, A. Conversion disorder: advances in our understanding. CMAJ. 2011 May 17;183(8):915–20.10.1503/cmaj.110490CrossRefGoogle ScholarPubMed

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Jaghab, K, Skodnek, KB, Padder, TA. Munchausen’s syndrome and other factitious disorders in children: case series and literature review.Psychiatry (Edgmont). 2006 Mar;3(3):46–55.Google ScholarPubMed

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsmGoogle Scholar

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

Castellano, JM, Kim, J, Stewart, FR, Jiang, H, DeMattos, RB, Patterson, BW, et al. Human APOE isoforms differentially regulate brain amyloid-β peptide clearance. Sci Transl Med. 2011 Jun 29;3(89):89ra57.10.1126/scitranslmed.3002156CrossRefGoogle ScholarPubMed

Farrer, LA, Cupples, LA, Haines, JL, Hyman, B, Kukull, WA, Mayeux, R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997 Oct 22;278(16):1349–56.10.1001/jama.1997.03550160069041CrossRefGoogle ScholarPubMed

Laurin, D, Verreault, R, Lindsay, J, MacPherson, K, Rockwood, K. Physical activity and risk of cognitive impairment and dementia in elderly persons. Arch Neurol. 2001 Mar 1;58(3). Available from: http://archneur.jamanetwork.com/article.aspx?doi=10.1001/archneur.58.3.498CrossRefGoogle ScholarPubMed

Hodkinson, HM. Evaluation of a mental test score for assessment of mental impairment in the elderly. Age Ageing. 1972 Nov;1(4):233–8.10.1093/ageing/1.4.233CrossRefGoogle ScholarPubMed

Hazan, E, Frankenburg, F, Brenkel, M, Shulman, K. The test of time: a history of clock drawing. Int J Geriatr Psychiatry. 2018 Jan;33(1):e22–30.10.1002/gps.4731CrossRefGoogle Scholar

Folstein, MF, Folstein, SE, McHugh, PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–98.Google ScholarPubMed

Nasreddine, ZS, Phillips, NA, Bédirian, V, Charbonneau, S, Whitehead, V, Collin, I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695–9.10.1111/j.1532-5415.2005.53221.xCrossRefGoogle Scholar

Mathuranath, PS, Nestor, PJ, Berrios, GE, Rakowicz, W, Hodges, JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology. 2000 Dec 12;55(11):1613–20.10.1212/01.wnl.0000434309.85312.19CrossRefGoogle ScholarPubMed

Crum, RM, Anthony, JC, Bassett, SS, Folstein, MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993 May 12;269(18):2386–91.10.1001/jama.1993.03500180078038CrossRefGoogle ScholarPubMed

Tsoi, KKF, Chan, JYC, Hirai, HW, Wong, SYS, Kwok, TCY. Cognitive tests to detect dementia: a systematic review and meta-analysis. JAMA Intern Med. 2015 Sep;175(9):1450–8.10.1001/jamainternmed.2015.2152CrossRefGoogle ScholarPubMed

Tombaugh, TN, McIntyre, NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc. 1992 Sep;40(9):922–35.10.1111/j.1532-5415.1992.tb01992.xCrossRefGoogle ScholarPubMed

Knopman, DS, DeKosky, ST, Cummings, JL, Chui, H, Corey-Bloom, J, Relkin, N, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001 May 8;56(9):1143–53.10.1212/WNL.56.9.1143CrossRefGoogle Scholar

Woods, B, Aguirre, E, Spector, AE, Orrell, M. Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. 2012 Feb 15;2012(2):CD005562.Google Scholar

Graff, MJL, Vernooij-Dassen, MJM, Thijssen, M, Dekker, J, Hoefnagels, WHL, Rikkert, MGMO. Community based occupational therapy for patients with dementia and their care givers: randomised controlled trial. BMJ. 2006 Dec 9;333(7580):1196.10.1136/bmj.39001.688843.BECrossRefGoogle ScholarPubMed

White, H. Weight change in Alzheimer’s disease. J Nutr Health Aging. 1998;2(2):110–2.Google ScholarPubMed

Forbes, D, Forbes, SC, Blake, CM, Thiessen, EJ, Forbes, S. Exercise programs for people with dementia. Cochrane Database Syst Rev. 2015 Apr 15;2015(4):CD006489.Google ScholarPubMed

Teri, L, Gibbons, LE, McCurry, SM, Logsdon, RG, Buchner, DM, Barlow, WE, et al. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA. 2003 Oct 15;290(15):2015–22.10.1001/jama.290.15.2015CrossRefGoogle ScholarPubMed

Pitkälä, KH, Pöysti, MM, Laakkonen, ML, Tilvis, RS, Savikko, N, Kautiainen, H, et al. Effects of the Finnish Alzheimer Disease Exercise Trial (FINALEX): a randomized controlled trial. JAMA Intern Med. 2013 May 27;173(10):894–901.10.1001/jamainternmed.2013.359CrossRefGoogle ScholarPubMed

National Institute for Health and Care Excellence (NICE). Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease. Technology appraisal guidance [TA217]. NICE; 2011. Available from: www.nice.org.uk/guidance/ta217Google Scholar

Sano, M, Ernesto, C, Thomas, RG, Klauber, MR, Schafer, K, Grundman, M, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. The Alzheimer’s Disease Cooperative Study. N Engl J Med. 1997 Apr 24;336(17):1216–22.10.1056/NEJM199704243361704CrossRefGoogle ScholarPubMed

Farina, N, Llewellyn, D, Isaac, MGEKN, Tabet, N. Vitamin E for Alzheimer’s dementia and mild cognitive impairment. Cochrane Database Syst Rev. 2017 Jan 27;2017(1):CD002854.Google Scholar

Birks, J, Grimley Evans, J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2009 Jan 21;2009(1):CD003120.Google Scholar

DeKosky, ST, Williamson, JD, Fitzpatrick, AL, Kronmal, RA, Ives, DG, Saxton, JA, et al. Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA. 2008 Nov 19;300(19):2253–62.10.1001/jama.2008.683CrossRefGoogle ScholarPubMed

Cummings, JL. Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations. Am J Geriatr Psychiatry. 2003;11(2):131–45.10.1097/00019442-200303000-00004CrossRefGoogle ScholarPubMed

Clark, CM, Karlawish, JHT. Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies. Ann Intern Med. 2003 Mar 4;138(5):400–10.10.7326/0003-4819-138-5-200303040-00010CrossRefGoogle ScholarPubMed

Wei, LA, Fearing, MA, Sternberg, EJ, Inouye, SK. The Confusion Assessment Method: a systematic review of current usage. J Am Geriatr Soc. 2008 May;56(5):823–30.10.1111/j.1532-5415.2008.01674.xCrossRefGoogle Scholar

Burns, A. Delirium. J Neurol, Neurosurg Psychiatry. 2004 Mar 1;75(3):362–7.10.1136/jnnp.2003.023366CrossRefGoogle ScholarPubMed

Mega, MS, Cummings, JL, Fiorello, T, Gornbein, J. The spectrum of behavioral changes in Alzheimer’s disease. Neurology. 1996 Jan;46(1):130–5.10.1212/WNL.46.1.130CrossRefGoogle ScholarPubMed

Lyketsos, CG, Steinberg, M, Tschanz, JT, Norton, MC, Steffens, DC, Breitner, JC. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000 May;157(5):708–14.10.1176/appi.ajp.157.5.708CrossRefGoogle Scholar

Lyketsos, CG, Lopez, O, Jones, B, Fitzpatrick, AL, Breitner, J, DeKosky, S. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002 Sep 25;288(12):1475–83.10.1001/jama.288.12.1475CrossRefGoogle ScholarPubMed

Gallagher-Thompson, D, Brooks, JO, Bliwise, D, Leader, J, Yesavage, JA. The relations among caregiver stress, “sundowning” symptoms, and cognitive decline in Alzheimer’s disease. J Am Geriatr Soc. 1992 Aug;40(8):807–10.10.1111/j.1532-5415.1992.tb01853.xCrossRefGoogle ScholarPubMed

Zarit, SH, Reever, KE, Back-Peterson, J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 1980;20:649–55.10.1093/geront/20.6.649CrossRefGoogle Scholar

Atypical antipsychotics in the elderly. Med Lett Drugs Ther. 2005 Aug 1;47(1214):61–2.Google Scholar

Kuehn, BM. FDA warns antipsychotic drugs may be risky for elderly. JAMA. 2005 May 25;293(20):2462.Google ScholarPubMed

Porsteinsson, AP, Drye, LT, Pollock, BG, Devanand, DP, Frangakis, C, Ismail, Z, et al. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. 2014 Feb 19;311(7):682–91.10.1001/jama.2014.93CrossRefGoogle ScholarPubMed

Pollock, BG, Mulsant, BH, Rosen, J, Sweet, RA, Mazumdar, S, Bharucha, A, et al. Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. Am J Psychiatry. 2002 Mar;159(3):460–5.10.1176/appi.ajp.159.3.460CrossRefGoogle ScholarPubMed

Qiu, C, Kivipelto, M, von Strauss, E. Epidemiology of Alzheimer’s disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009;11(2):111–28.10.31887/DCNS.2009.11.2/cqiuCrossRefGoogle ScholarPubMed

Goldman, JS, Hahn, SE, Catania, JW, LaRusse-Eckert, S, Butson, MB, Rumbaugh, M, et al. Genetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors. Genet Med. 2011 Jun;13(6):597–605.10.1097/GIM.0b013e31821d69b8CrossRefGoogle ScholarPubMed

Slooter, AJC, Cruts, M, Hofman, A, Koudstaal, PJ, van der Kuip, D, de Ridder, M a. J, et al. The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study. Neurology. 2004 Apr 13;62(7):1196–8.10.1212/01.WNL.0000118302.66674.E1CrossRefGoogle ScholarPubMed

Myers, RH, Schaefer, EJ, Wilson, PW, D’Agostino, R, Ordovas, JM, Espino, A, et al. Apolipoprotein E epsilon4 association with dementia in a population-based study: the Framingham study. Neurology. 1996 Mar;46(3):673–7.10.1212/WNL.46.3.673CrossRefGoogle Scholar

Birks, J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev. 2006 Jan 25;2006(1):CD005593.Google ScholarPubMed

Courtney, C, Farrell, D, Gray, R, Hills, R, Lynch, L, Sellwood, E, et al. Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): randomised double-blind trial. Lancet. 2004 Jun 26;363(9427):2105–15.Google ScholarPubMed

Ballard, C, Hanney, ML, Theodoulou, M, Douglas, S, McShane, R, Kossakowski, K, et al. The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial. Lancet Neurol. 2009 Feb;8(2):151–7.10.1016/S1474-4422(08)70295-3CrossRefGoogle ScholarPubMed

American Geriatrics Society Ethics Committee and Clinical Practice and Models of Care Committee. American Geriatrics Society feeding tubes in advanced dementia position statement. J Am Geriatr Soc. 2014 Aug;62(8):1590–3.Google Scholar

Finucane, TE. Malnutrition, tube feeding and pressure sores: data are incomplete. J Am Geriatr Soc. 1995 Apr;43(4):447–51.10.1111/j.1532-5415.1995.tb05822.xCrossRefGoogle ScholarPubMed

Finucane, TE, Bynum, JP. Use of tube feeding to prevent aspiration pneumonia. Lancet. 1996 Nov 23;348(9039):1421–4.10.1016/S0140-6736(96)03369-7CrossRefGoogle ScholarPubMed

Parliament of the United Kingdom. Mental Capacity Act 2005, c. 9. Available from: www.legislation.gov.uk/ukpga/2005/9/contents/enactedGoogle Scholar

Banks v Goodfellow (1870) LR 5 QB 549.Google Scholar

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

Hollis, C, Hall, CL, Guo, B, James, M, Boadu, J, Groom, MJ, et al. The impact of a computerised test of attention and activity (QbTest) on diagnostic decision-making in children and young people with suspected attention deficit hyperactivity disorder: single-blind randomised controlled trial. J Child Psychol Psychiatry. 2018 Dec;59(12):1298–308.10.1111/jcpp.12921CrossRefGoogle Scholar

Mueller, F, Brozovich, R, Johnson, CB. Conners’ Rating Scales-Revised (CRS-R). Diagnostique. 1999 Mar;24(1–4):83–97.10.1177/153450849902401-409CrossRefGoogle Scholar

Wolraich, ML. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol. 2003 Dec 1;28(8):559–68.10.1093/jpepsy/jsg046CrossRefGoogle Scholar

Kessler, RC, Adler, L, Ames, M, Demler, O, Faraone, S, Hiripi, E, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005 Feb;35(2):245–56.10.1017/S0033291704002892CrossRefGoogle Scholar

Schachter, HM, Pham, B, King, J, Langford, S, Moher, D. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ. 2001 Nov 27;165(11):1475–88.Google ScholarPubMed

Barbaresi, WJ, Katusic, SK, Colligan, RC, Weaver, AL, Leibson, CL, Jacobsen, SJ. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. J Dev Behav Pediatr. 2006 Feb;27(1):1–10.10.1097/00004703-200602000-00001CrossRefGoogle ScholarPubMed

Storebø, OJ, Pedersen, N, Ramstad, E, Kielsholm, ML, Nielsen, SS, Krogh, HB, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents: assessment of adverse events in non-randomised studies. Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069.Google ScholarPubMed

Moran, LV, Ongur, D, Hsu, J, Castro, VM, Perlis, RH, Schneeweiss, S. Psychosis with methylphenidate or amphetamine in patients with ADHD. N Engl J Med. 2019 Mar 21;380(12):1128–38.10.1056/NEJMoa1813751CrossRefGoogle ScholarPubMed

Samuels, JA, Franco, K, Wan, F, Sorof, JM. Effect of stimulants on 24-h ambulatory blood pressure in children with ADHD: a double-blind, randomized, cross-over trial. Pediatr Nephrol. 2006 Jan;21(1):92–5.10.1007/s00467-005-2051-1CrossRefGoogle ScholarPubMed

Fay, TB, Alpert, MA. Cardiovascular effects of drugs used to treat attention-deficit/hyperactivity disorder. Part 2: impact on cardiovascular events and recommendations for evaluation and monitoring. Cardiol Rev. 2019;27(4):173–8.Google ScholarPubMed

Greenhill, LL, Swanson, JM, Hechtman, L, Waxmonsky, J, Arnold, LE, Molina, BSG, et al. Trajectories of growth associated with long-term stimulant medication in the multimodal treatment study of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2020 Aug;59(8):978–89.10.1016/j.jaac.2019.06.019CrossRefGoogle ScholarPubMed

Wilens, TE, Faraone, SV, Biederman, J, Gunawardene, S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003 Jan;111(1):179–85.10.1542/peds.111.1.179CrossRefGoogle ScholarPubMed

Bangs, ME, Tauscher-Wisniewski, S, Polzer, J, Zhang, S, Acharya, N, Desaiah, D, et al. Meta-analysis of suicide-related behavior events in patients treated with atomoxetine. J Am Acad Child Adolesc Psychiatry. 2008 Feb;47(2):209–18.10.1097/chi.0b013e31815d88b2CrossRefGoogle ScholarPubMed

Davies, M, Coughtrie, A, Layton, D, Shakir, SAS. Use of atomoxetine and suicidal ideation in children and adolescents: results of an observational cohort study within general practice in England. Eur Psychiatr. 2017 Jan;39:11–6.10.1016/j.eurpsy.2016.06.005CrossRefGoogle ScholarPubMed

Sonuga-Barke, EJS, Brandeis, D, Cortese, S, Daley, D, Ferrin, M, Holtmann, M, et al. Nonpharmacological interventions for ADHD: systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013 Mar;170(3):275–89.10.1176/appi.ajp.2012.12070991CrossRefGoogle ScholarPubMed

Bloch, MH, Qawasmi, A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011 Oct;50(10):991–1000.10.1016/j.jaac.2011.06.008CrossRefGoogle ScholarPubMed

Barragán, E, Breuer, D, Döpfner, M. Efficacy and safety of omega-3/6 fatty acids, methylphenidate, and a combined treatment in children with ADHD. J Atten Disord. 2017 Mar;21(5):433–41.10.1177/1087054713518239CrossRefGoogle Scholar

Wolraich, ML, Hagan, JF, Allan, C, Chan, E, Davison, D, Earls, M, et al. Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. 2019 Oct;144(4):e20192528.10.1542/peds.2019-2528CrossRefGoogle ScholarPubMed

Sampson, HA, Aceves, S, Bock, SA, James, J, Jones, S, Lang, D, et al. Food allergy: a practice parameter update – 2014. J Allergy Clin Immunol. 2014 Nov;134(5):1016–1025.e43.10.1016/j.jaci.2014.05.013CrossRefGoogle ScholarPubMed

National Institute for Health and Care Excellence (NICE). Attention deficit hyperactivity disorder: diagnosis and management. NICE guideline [NG87]. NICE; 2018. Available from: www.nice.org.uk/guidance/NG87Google Scholar

Rojas, NL, Chan, E. Old and new controversies in the alternative treatment of attention-deficit hyperactivity disorder. Ment Retard Dev Disabil Res Rev. 2005;11(2):116–30.Google ScholarPubMed

Nigg, JT, Lewis, K, Edinger, T, Falk, M. Meta-analysis of attention-deficit/hyperactivity disorder or attention-deficit/hyperactivity disorder symptoms, restriction diet, and synthetic food color additives. J Am Acad Child Adolesc Psychiatry. 2012 Jan;51(1):86–97.e8.10.1016/j.jaac.2011.10.015CrossRefGoogle ScholarPubMed

Millichap, JG, Yee, MM. The diet factor in attention-deficit/hyperactivity disorder. Pediatrics. 2012 Feb;129(2):330–7.10.1542/peds.2011-2199CrossRefGoogle ScholarPubMed

Jankovic, J, Kurlan, R. Tourette syndrome: evolving concepts. Mov Disord. 2011 May;26(6):1149–56.10.1002/mds.23618CrossRefGoogle ScholarPubMed

World Health Organization. International classification of diseases, 11th edition (ICD-11). Geneva: World Health Organization; 2024. Available from: https://icd.who.int/enGoogle Scholar

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th edition, text revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. Available from: www.psychiatry.org/psychiatrists/practice/dsm.Google Scholar

Semple, D, Smyth, R. Oxford handbook of psychiatry, 4th edition. Oxford: Oxford University Press; 2019.10.1093/med/9780198795551.001.0001CrossRefGoogle Scholar

White, SW, Oswald, D, Ollendick, T, Scahill, L. Anxiety in children and adolescents with autism spectrum disorders. Clin Psychol Rev. 2009 Apr;29(3):216–29.10.1016/j.cpr.2009.01.003CrossRefGoogle ScholarPubMed